Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia.
- Resource Type
- Article
- Authors
- Sonnenschein, Susan F; Grace, Anthony A
- Source
- Schizophrenia Bulletin; Nov2021, Vol. 47 Issue 6, p1806-1814, 9p
- Subject
- NEURAL physiology
DRUG therapy for schizophrenia
BIOLOGICAL models
HIPPOCAMPUS (Brain)
IN vivo studies
ANIMAL experimentation
PUBERTY
CELL receptors
DOPAMINE
RATS
COMPARATIVE studies
ELECTROPHYSIOLOGY
ANTIPSYCHOTIC agents
PHARMACODYNAMICS
ADULTS
- Language
- ISSN
- 05867614
Copyright of Schizophrenia Bulletin is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)